Navigate Up
UPMC/University of Pittsburgh Schools of the Health Sciences
Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.

Some Cancer Patients May Benefit From a Less Aggressive Approach to Stem Cell Transplant Therapy

WASHINGTON, December 3, 2001 — Conventional wisdom over the past 30 years has developed a well-defined path for physicians who recommend stem cell transplants for their cancer patients – destroy the blood cell factory and the immune system completely before you can rebuild it. But to paraphrase George Gershwin, new research indicates it ain’t necessarily so.

“In the past, this so-called ‘conditioning regimen’ has involved high doses of cancer chemotherapy drugs, sometimes in combination with radiation treatments to the entire body,” said Andrew Yeager, M.D., a professor of medicine and pediatrics at the University of Pittsburgh School of Medicine. “This intensive treatment was effective in getting rid of the patient’s blood cells and immune responses, but had its own toxicities to normal vital organs and tissues. The transplant patient’s damaged cells set off a storm of cytokines – proteins that cause inflammation – which in turn caused more transplant-related complications.”

New research is beginning to indicate that cell transplantation without such aggressive conditioning regimens can still be effective in treating certain cancers, continued the physician, who is also director of stem cell transplantation at the University of Pittsburgh Cancer Institute.

Dr. Yeager made a presentation, “Is Less Really More? An Update on Nonmyeloablative Hematopoietic Cell Transplantation,” at the Second Annual Conference on Regenerative Medicine, a gathering of clinicians and other specialists in the fields of stem cell research, medicine and biotechnology that ends Tuesday at the Renaissance Washington, D.C. Hotel.

Hematopoietic cells are progenitor cells found in adult bone marrow and, to a lesser extent, in the peripheral bloodstream. Researchers believe these cells, also known as CD34-positive cells, can become blood cells and immune system cells.

“They can be used to build a new blood-cell factory,” said Dr. Yeager, who was featured in a CBS 60 Minutes II report on stem cell transplantation for sickle cell anemia on Nov. 28. “But the key question is, can the graft survive? The goal is to get these cells in so the patient doesn’t reject them.”

Using a less destructive conditioning regimen may be a viable option, said Dr. Yeager.

“Experiments using a mouse model have shown that you can get a low level of stem cell growth from transplant without doing anything to damage the native immune system,” he added. “And other studies have found that there still is a lot of growth with just immunosuppression that doesn’t destroy the bone marrow first.”

Thus far, stem cell transplant therapies with less intensive conditioning treatments seem most effective for cancers such as leukemia and lymphoma and a cancer of the kidney called renal cell carcinoma. Because of many subtle differences between cancers, however, it is difficult to determine a single treatment option, or even a single way of carrying out a treatment.

“We need to refine the regimens,” said Dr. Yeager. “Over time, the hope is to increase donor cells that rebuild healthy blood cells and get rid of cancer cells in the recipient without causing the acute problems that can happen after regular full-dose transplants.”

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com